Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
Evaluation of a Theory-Driven Manualized Approach to Improving New Learning and Memory in MS
批准号:
10380805
负责人:
NANCY D. CHIARAVALLOTI
金额:
$36.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-05-10 至 2025-03-31
关键词:
AddressAftercareBrainCaregiver BurdenCognitionCognitive ScienceDataDevelopmentDisabled PersonsDouble-Blind MethodEducational process of instructingEvaluationGenerationsImpairmentIndividualInterventionLearningLifeLiteratureManualsMeasuresMedical centerMemoryMemory impairmentMethodologyMultiple SclerosisNational Institute of Child Health and Human DevelopmentNeuropsychologyOccupationalOutcomeOutcome MeasureParticipantPatientsPerformancePopulationPopulation InterventionProtocols documentationPublicationsQuality of lifeQuestionnairesRecommendationRehabilitation therapyResearchResearch DesignRetrievalShiveringSocial FunctioningSocietiesStandardizationStructureTechniquesTimeTrainingTreatment ProtocolsUnited States National Institutes of HealthWorkcognitive performancecognitive rehabilitationdaily functioningdesigndisabilityefficacious treatmentefficacy evaluationefficacy testingevidence basefollow-upimprovedinnovationinterestmultiple sclerosis patientneural correlateneuroimagingneuromechanismnoveloptimismrandomized placebo-controlled clinical trialrandomized, clinical trialsreduce symptomsrehabilitation researchremediationself testingsocialstandardize measuretheoriestreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Impairments in new learning and memory are common in Multiple Sclerosis (MS) and negatively impact
several aspects of everyday life, including occupational and social functioning. Despite the demand for learning
and memory treatments few cognitive rehabilitation (CR) protocols to date are supported by Class I research
evidence, thereby limiting the degree to which potentially efficacious treatments may be applied to MS. To
address this critical need, the presently proposed randomized clinical trial (RCT) examines the efficacy of an 8-session CR protocol encompassing training in the application of three strategies (self-generation, spaced
learning and self-testing) with the greatest empirical evidence to treat impaired learning and memory in persons
with MS, Strategy-based Training to Enhance Memory (STEM). The currently proposed double-blind placebo-controlled randomized clinical trial (RCT) addresses a central objective highlighted in the NCMRR 2016
Research Plan by seeking to reduce “symptoms and secondary conditions associated with disability
through the development, adaptation or evaluation on interventions” (p. 1531).
We will conduct a double-blind, placebo-controlled RCT, administering STEM to 120 participants with MS
who evidence NLM deficits. Outcome will be assessed via 3 mechanisms, an Assessment of Global Functioning
(AGF), which examines everyday functioning and quality of life, a Neuropsychological Evaluation (NPE) to
examine objective cognitive performance, and neuroimaging to elucidate neural mechanisms of STEM and its
mechanisms. The examination of daily life activities as an a priori endpoint in this RCT is a highly innovative
aspect of the currently proposed work, highlighted as a significant gap in the rehabilitation literature by the
NCMRR1. We will additionally evaluate the longer-term efficacy of STEM on everyday functioning and NPE
through a 6-month follow-up evaluation and evaluate the impact of booster sessions in maintaining the treatment
effect over time. Importantly, the rigorous research design employed in the current study is highly responsive to
the objectives set forth by the NCMRR in their most recent research plan, to “increase the quality of evidence
for rehabilitation interventions …through increased focus on the design…and outcomes of these
interventions” (p. 152). Such “evidence based approaches are essential for rehabilitation research”
(NCMRR, 20162)
Supported by strong preliminary data, this novel and innovative intervention has the potential to significantly
remediate NLM deficits in persons with MS, ultimately leading to improved social and occupational functioning
(i.e., participation) and overall QOL. Results of the current study will provide Class I evidence for the STEM
treatment protocol for persons with MS due to the methodologically rigorous study design. Finally, the currently
proposed work is well grounded in a long line of memory rehabilitation work at KF led by the current PI and
represents the next systematic step in the line of work examining strategy training.
1. National Center for Medical Rehabilitation Research (NCMRR): Overview.
https://www.nichd.nih.gov/about/org/ncmrr/Pages/overview.aspx. Accessed September 14, 2017.
2. The Eunice Kennedy Shiver National Institute of Child Health and Human Development and the NIH
Medical Rehabilitation Coordinating Committee. National Institutes of Health (NIH) Rehabilitation Plan
on Rehabilitation: Moving the Field Forward. 2016. Accessed September 14, 2017.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Use of the KF Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment
-
批准号:10444012
-
项目类别:
-
资助金额:$59.98万
-
财政年份:2022
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
Use of the KF Modified Story Memory Technique to Improve New Learning and Memory in Individuals with Mild Cognitive Impairment
-
批准号:10683197
-
项目类别:
-
资助金额:$56.05万
-
财政年份:2022
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
Improving Learning in MS: A Randomized Clinical Trial
-
批准号:6818525
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2004
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
Improving Learning in MS: A Randomized Clinical Trial
-
批准号:7408119
-
项目类别:
-
资助金额:$64.96万
-
财政年份:2004
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
Improving Learning in MS: A Randomized Clinical Trial
-
批准号:7216900
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2004
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
Improving Learning in MS: A Randomized Clinical Trial
-
批准号:7052886
-
项目类别:
-
资助金额:$26.89万
-
财政年份:2004
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
Improving Learning in MS: A Randomized Clinical Trial
-
批准号:6908132
-
项目类别:
-
资助金额:$27.54万
-
财政年份:2004
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
Improving Learning in MS: A Randomized Clinical Trial
-
批准号:7315602
-
项目类别:
-
资助金额:$41.07万
-
财政年份:2003
-
负责人:NANCY D. CHIARAVALLOTI
-
依托单位:
海外基金